| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/27/2003 | US20030040511 Administering physiologically compatible dithiocarbamate-containing free radical scavenger for the in vivo reduction of free radical levels in a subject |
| 02/27/2003 | US20030040510 Selective estrogen receptor modulators in combination with estrogens |
| 02/27/2003 | US20030040509 Methods and compositions for treating diseases associated with excesses in ACE |
| 02/27/2003 | US20030040508 Altering the conformational equilibrium of the A- ring of a 1 alpha -hydroxylated vitamin D compound to favor a chair conformation for A-ring that presents the 1 alpha-hydroxyl in an axial orientation |
| 02/27/2003 | US20030040507 Pharmaceutical composition comprising ifosfamide and carnitine |
| 02/27/2003 | US20030040504 For removing mammalian ectoparasites and/or their eggs |
| 02/27/2003 | US20030040503 Monovalent saccharides and uses thereof |
| 02/27/2003 | US20030040502 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| 02/27/2003 | US20030040499 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 02/27/2003 | US20030040497 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/27/2003 | US20030040494 Application of water and organic solvent soluble invermectin for topical and oral use |
| 02/27/2003 | US20030040493 For therapy and prophylaxis of fungal infections |
| 02/27/2003 | US20030040492 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 02/27/2003 | US20030040491 Use of pentosan polysulfate to treat certain conditions of the prostate |
| 02/27/2003 | US20030040490 Drugs containing combined active ingredients |
| 02/27/2003 | US20030040487 Polymer complexes of glucuronoglucanes |
| 02/27/2003 | US20030040486 Alternating intrathecal administration to the mammal of a pharmaceutically effective dose of opioid receptor agonist for first period of time, and dose of at least one opioid receptor-like receptor 1 agonist for a second period of time |
| 02/27/2003 | US20030040484 Administering a therapeutically-effective amount of an angiotensin converting enzyme inhibitor and administering an aldosterone antagonist to reduce the death rate or the number of non-fatal hospitalizations |
| 02/27/2003 | US20030040483 Compounds with growth hormone releasing properties |
| 02/27/2003 | US20030040479 Rotational intrathecal analgesia method and device |
| 02/27/2003 | US20030040468 For therapy of respiratory distress of the lungs |
| 02/27/2003 | US20030040464 Method of treating or preventing attention defecit hyperactivity disorder |
| 02/27/2003 | US20030040463 Reducing pathological neovascularization in a human by administering to the human an agent capable of interfering with Ang2-mediated biological effects |
| 02/27/2003 | US20030040111 Differentiated cells suitable for human therapy |
| 02/27/2003 | US20030040095 Generation of preferential protein for use in the trement of thrombosis and heart defscts; obtain cells, transform with vector containing preferential protein, recover transformed cells, propagate, recover protein |
| 02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
| 02/27/2003 | US20030040046 Netrin receptors |
| 02/27/2003 | US20030040028 Analgesic screening method and composition |
| 02/27/2003 | US20030039977 Carbamate-derivatized nucleosides and oligonucleosides |
| 02/27/2003 | US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer |
| 02/27/2003 | US20030039740 Composition for enteral nutrition comprising fibres |
| 02/27/2003 | US20030039708 Non-ma huang herb weight loss product |
| 02/27/2003 | US20030039705 Triterpene compositions and methods for use thereof |
| 02/27/2003 | US20030039704 Dermatological preparations |
| 02/27/2003 | US20030039702 Antiviral drugs containing heteropolyanions |
| 02/27/2003 | US20030039701 Mixture containing animal extract from deer antlers |
| 02/27/2003 | US20030039692 Sustained release oral formulations |
| 02/27/2003 | US20030039691 Compression coatings |
| 02/27/2003 | US20030039690 Controlling concentration of enzyme inhibitor in blood; enteric coating |
| 02/27/2003 | US20030039689 Prodrug in polymer matrix; insertion into body |
| 02/27/2003 | US20030039687 Using Carbomer |
| 02/27/2003 | US20030039686 Increased absorption; aqueous solution containing fatty acid, or salt thereof |
| 02/27/2003 | US20030039683 Multilayer binding; lamellar surface structure |
| 02/27/2003 | US20030039681 Conjugated linoleic acid; prevent damage to mammary glands |
| 02/27/2003 | US20030039680 Buccal, polar and non-polar spray or capsule |
| 02/27/2003 | US20030039677 Apparatus and method for delivering compounds to a living organism |
| 02/27/2003 | US20030039675 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/27/2003 | US20030039670 Cosmetics |
| 02/27/2003 | US20030039669 Use of a composition containing an effective quantity of at least one chelating agent for partially or totally reducing the symptoms associated with histamine release in the organism |
| 02/27/2003 | US20030039665 Inducing immunology response; administering by nose |
| 02/27/2003 | US20030039661 Methods, compositions and kits for preserving antigenicity |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039651 Administering tumor necrosis factor inhibitors, interleukin -1, -6, or -8 inhibitors, FAS (ligand) gene/protein inhibitors or interferon gamma inhibitors; nerve disorder treatments |
| 02/27/2003 | US20030039648 Compositions and methods for the diagnosis and treatment of tumor |
| 02/27/2003 | US20030039647 Tetraspan protein and uses thereof |
| 02/27/2003 | US20030039643 Investigation, diagnosis and treatment of subjects suspected of or suffering from alpha-N- acetylglucosaminidase deficiency |
| 02/27/2003 | US20030039640 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus |
| 02/27/2003 | US20030039633 A replication-competent adenovirus vector comprising an adenovirus gene essential for replication; use as antitumor agent |
| 02/27/2003 | US20030039628 Treating cancer or viral diseases for enhancing T-cell proliferation by administering an effective amount compound that inhibits the production or release of intercellular reactive oxygen metabolites |
| 02/27/2003 | US20030039627 Administering to the patient a therapeutically effective amount of an amine containing polymer |
| 02/27/2003 | US20030039626 Fat-binding polymers |
| 02/27/2003 | US20030039623 An opaque or clear conditioner for hair; improves the wet combing and dry combing properties of hair |
| 02/27/2003 | US20030039619 Cosmetic or dermatological formulations |
| 02/27/2003 | US20030039616 Antimicrobial flavor and oral care composition containing the same |
| 02/27/2003 | US20030039615 Method for treating bronchial constriction and bronchospasm |
| 02/27/2003 | US20030039614 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil |
| 02/27/2003 | US20030038836 Web map tool |
| 02/27/2003 | US20030037701 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/27/2003 | US20030037673 Method and system for treating air with an iodinated resin |
| 02/27/2003 | DE4200555C2 Herstellung eines Kamillenextraktes mit antimikrobiellen Eigenschaften Producing a chamomile extract with antimicrobial properties |
| 02/27/2003 | DE20219661U1 Composition for treating obesity and reducing cholesterol levels, comprising low-esterified polysaccharide and swellable material |
| 02/27/2003 | DE20219657U1 Composition for treatment of obesity, comprising ginseng component and insoluble material swellable in gastrointestinal fluid |
| 02/27/2003 | CA2493349A1 Delayed and sustained drug release |
| 02/27/2003 | CA2460352A1 Composition and transdermal drug delivery device |
| 02/27/2003 | CA2459692A1 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | CA2459647A1 Use of s-nitrosothiol signaling to treat disordered control of breathing |
| 02/27/2003 | CA2459434A1 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders |
| 02/27/2003 | CA2458801A1 Therapeutic tropane compounds |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2458068A1 Methods and compositions for treating apoptosis associated disorders |
| 02/27/2003 | CA2457932A1 Sodium channel regulators and modulators |
| 02/27/2003 | CA2457799A1 Method and quantification assay for determining c-kit/scf/pakt status |
| 02/27/2003 | CA2457789A1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 02/27/2003 | CA2457783A1 Oligonucleotide compositions and their use to induce apoptosis |
| 02/27/2003 | CA2457745A1 Combination therapy for the treatment of cancer |
| 02/27/2003 | CA2457644A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 02/27/2003 | CA2457611A1 Novel molecular target for neurotoxicity |
| 02/27/2003 | CA2457453A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 02/27/2003 | CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | CA2457436A1 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 02/27/2003 | CA2457405A1 Compositions and methods relating to benzodiazepine compounds |
| 02/27/2003 | CA2457356A1 Canine cardiac diet |
| 02/27/2003 | CA2457321A1 Combinatorial methods for inducing cancer cell death |
| 02/27/2003 | CA2457148A1 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 02/27/2003 | CA2457142A1 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 02/27/2003 | CA2457066A1 Human protooncogene kg-20 and protein encoded therein |
| 02/27/2003 | CA2457055A1 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 02/27/2003 | CA2457041A1 Novel combination |
| 02/27/2003 | CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 02/27/2003 | CA2457033A1 A medecine for cardiac failure |